SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 OrthoBio Market Recap.

Up 3.4% YoY, the OrthoBio market is off to a good start. Companies that are surpassing growth expectations tend to have differentiated products, focused efforts and incremental pull through from synergistic sales strategies. Market subtleties like reimbursement, pricing pressures and market loss due to newer competition continue to afflict some companies and segments...

Among the many topics covered in the full Q118 OrthoBio Market Recap are: 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Spine Market Recap.

While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...

Among the many topics covered in the Q118 Spine Market Recap are:

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Extremities Market Recap.

The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.

Among the many topics covered in the Q118 Extremities Market Recap are:

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Total Joints Market Recap.

SmartTRAK, the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies,  is excited to be attending the 19th EFORT Congress, the largest platform for European Orthopedics to exchange knowledge and experience within Europe and with colleagues from other parts of the world, to be held in Barcelona, Spain, May 30-June 1, 2018.

Christopher McCarthy,  Vice President Corporate Accounts, Orthopedics and Neuro and Tim Jeavons, Director, European Orthopaedic Content & Sales will be there representing SmartTRAK. Please contact us if you would like a meeting to discuss how SmartTRAK can help you.

Pricing pressure and commoditization slows Soft Tissue Fixation Market but 2017 still finishes strong

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Soft Tissue Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 Soft Tissue Fixation Market Recap are:

SmartTRAK is excited to be attending ISASS18 - The International Society for the Advancement of Spine Surgery - annual meeting, April 11-13 in Toronto, Canada.

Julianne Burns, Senior Analyst, Spine; Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro; and Michelle Calderon, Acc't Manager, Orthopedics will be there representing SmartTRAK. Please contact us if you would like a meeting.

Spine is ending a Slow Year on a Slightly More Positive Note

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spine Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Spine Market Recap are:

Gains in sports medicine, extremities, advanced biologics and joint fluid offset softening spine market

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 OrthoBio Market Recap and Financial Dashboard.

Despite some challenges in 2017, the US OrthoBio market finished strong, growing 5.3% to $3.46B. Gains in Sports Medicine, Extremities, Advanced Biologics and Joint Fluid countered the softening Spine market and lower growth rates of core biologics. Positive results stemmed from incremental pull through revenue from synergistic sales strategies, entry of new companies, introduction of new products, growth in new surgeon users and use of biologics in non-traditional applications ...

Among the topics covered in the Q417, FY17 OrthoBio Market Recap are: